CAXTON CORP
CIK 0001388551
Annualised vol
7.594737%
Beta
0.292147
HHI
1514.065553
Top-10 weight
100.0%
VaR 95%
0.73957%
VaR 99%
1.266659%
Max drawdown
13.979074%
Matched value
40.708428%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| - | SPACE EXPLORATION TECHN CORP | PUT | 84615Q103 | 445,346 | 24.03 | 2606.0 | |
| - | BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 377,128 | 20.35 | 754.0 | |
| GOOGL | NEW | ALPHABET INC | CAP STK CL A | 02079K305 | 246,906 | 13.32 | 691.0 |
| - | VANGUARD INDEX FDS | S&P 500 ETF SHS | 922908363 | 233,094 | 12.58 | 339.0 | |
| BX | NEW | BLACKSTONE INC | COM | 09260D107 | 188,218 | 10.16 | 1597.0 |
| KYTX | REDUCED | KYVERNA THERAPEUTICS INC | COM | 501976104 | 110,009 | 5.94 | 12347.0 |
| LXEO | ADDED | LEXEO THERAPEUTICS INC | COM | 52886X107 | 78,959 | 4.26 | 16962.0 |
| XFOR | UNCHANGED | X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | 72,650 | 3.92 | 15557.0 |
| IKT | UNCHANGED | INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | 57,759 | 3.12 | 28453.0 |
| - | ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 43,358 | 2.34 | 20946.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 1,853,427 | 10 | 7.594737 | 0.292147 | 13.979074 |
| 2026-03-31 | 2026-05-14 | 4,024,354 | 7 | 1.512767 | 0.008225 | 7.988221 |
| 2025-12-31 | 2026-02-13 | 4,279,210 | 11 | 4.54091 | 0.037657 | 16.315236 |
| 2025-09-30 | 2025-11-14 | 22,859,400 | 12 | 27.982275 | 0.101803 | 51.544595 |
| 2025-03-31 | 2025-05-15 | 5,080,780 | 12 | 26.033172 | 0.100683 | 49.480207 |
| 2024-12-31 | 2025-02-14 | 16,637,598 | 15 | 18.346894 | 0.100439 | 24.389809 |